Adverse events self-reported by patients with advanced non-small cell lung cancer treated with osimertinib or chemotherapy in the AURA3 trial

Sebastian, M. and Schuler, M. and Schulz, C. and Deschler-Baier, B. and Kimmich, M. and Hilgert-Daute, K. and Griesinger, F. (2018) Adverse events self-reported by patients with advanced non-small cell lung cancer treated with osimertinib or chemotherapy in the AURA3 trial. ONCOLOGY RESEARCH AND TREATMENT, 41 (suppl1). p. 111. ISSN 2296-5270, 2296-5262

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin II
Depositing User: Petra Gürster
Date Deposited: 23 Jun 2020 13:01
Last Modified: 23 Jun 2020 13:01
URI: https://pred.uni-regensburg.de/id/eprint/15427

Actions (login required)

View Item View Item